Protagonist Therapeutics
Discovers peptide medicines and earns collaboration economics from partnered ICOTYDE and rusfertide.
$146.05
After-hours close+1.78 (+1.23%)
At close$144.27(−3.50%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $2.19 | — | — |
| Aug 2026 | $2.27 | $2.29 | +0.9% |
| May 2026 | −$0.65 | $0.05 | +107.7% |
| Feb 2026 | −$0.53 | −$0.69 | −30.2% |
| Nov 2025 | −$0.59 | −$0.62 | −5.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| Aug 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | $2.19 | — | — | $219.9M | — | — |
| Aug 5, 2026 | $2.27 | $2.29 | +0.9% | $212.0M | $213.5M | +0.7% |
| May 5, 2026 | −$0.65 | $0.05 | +107.7% | $11.7M | $56.4M | +381.7% |
| Feb 25, 2026 | −$0.53 | −$0.69 | −30.2% | $8.7M | $7.4M | −14.9% |
| Nov 6, 2025 | −$0.59 | −$0.62 | −5.1% | $14.9M | $4.7M | −68.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 21, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 7, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 15, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 4, 2021 | ||||||
| Mar 10, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 10, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 12, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 7, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 7, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Sep 15, 2016 | ||||||
| Aug 12, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Sep 30, 2015 | ||||||
| Jun 30, 2015 | ||||||